Most markets have successfully rebounded from the financial crisis of 2008 and 2009. Stocks, bonds, gold, oil, copper and grains are all up big in the last 5 years.
But there is one market that has continued to lag. I'm talking about shipping rates. That shows up in the Baltic Dry Index, a global index of dry shipping rates that has continued to fall for the last five years, dropping from above 7,500 in 2008 to a recent low near 1,000.
That huge decline was driven by a surplus in shipping capacities that was built up into the financial crisis ahead of 2009. Because bringing a large ocean liner to market takes years, making it very difficult for the industry to adjust to economic volatility and downsize shipping capacities in a contraction.
But now, for the first time in years, the Baltic Dry Index is showing signals of a long-term bottom. And that has big implications for shipping stocks that have been absolutely crushed. Take a look at the big spike in the index below after a multi-year trend lower.
Top 5 Valued Companies To Invest In 2015: Westinghouse Solar Inc.(WEST)
Westinghouse Solar, Inc. engages in the design, manufacture, integration, and installation of solar power systems under the Westinghouse name. It offers its solar power systems for residential and commercial customers. The company also designs and distributes solar panels with integrated micro inverters (called as AC solar panels). The company sells its AC solar panels to solar installers, trade workers, and do-it-yourself customers through distribution partnerships, dealer network, and retail outlets. It has a strategic partnership with Real Goods Solar, whereby Real Goods Solar operates as an authorized dealer for westinghouse solar power systems for sale to its customers in California and Colorado markets. The company was formerly known as Akeena Solar, Inc. and changed its name to Westinghouse Solar, Inc. on Apr 14, 2011. Westinghouse Solar, Inc. was founded in 2001 and is headquartered in Campbell, California.
Advisors' Opinion:- [By Bryan Murphy]
It's fun to be right, but that doesn't always mean it's fruitful. I was right about Westinghouse Solar Inc. (OTCMKTS:WEST) being a breakout candidate when I explained the chart's most likely technical outcome. Though it took a little more than a week for WEST to actually perform as expected, it got there. Problem: It got there in spades, solving one problem but creating another. Though I'm still bullish on this solar play, we need a new roadmap.
- [By John Udovich]
Small cap solar stock Andalay Solar Inc (OTCMKTS: WEST) has largely cratered for investors�verses solar stock peers Real Goods Solar, Inc (NASDAQ: RSOL) and SolarCity Corp (NASDAQ: SCTY), but is the company finally turning itself around after a failed deal to be acquired?
Hot Shipping Stocks To Invest In 2014: Immunomedics Inc.(IMMU)
Immunomedics, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and marketing of monoclonal, antibody-based products for the treatment of cancer, autoimmune, and other serious diseases in the United States and Europe. The company?s products include epratuzumab, a Phase III clinical trail product for the treatment of systemic lupus erythematosus and non-Hodgkin?s lymphoma; Veltuzumab, a Phase I/II clinical study completed product for the treatment of patients with non-Hodgkin?s lymphoma, immune thrombocytopenic purpura, and chronic lymphocytic leukemia; Yttrium Y 90 Clivatuzumab tetraxetan, a humanized monoclonal antibody for pancreatic cancer that is in Phase Ib/II clinical trail; and Yttrium Y 90 epratuzumab tetraxetan, a Phase I/II clinical study product for patients with non-Hodgkin?s lymphoma. Its early phase clinical trial products comprise Milatuzumab, a transmembrane protein product for antibody-drug conjugate therapy. The com pany also develops Dock-and-Lock methodology for making fusion proteins and multifunctional antibodies, as well as a new method of delivering imaging and therapeutic agents selectively to disease, primarily different solid cancers. In addition, it markets and sells a diagnostic product, LeukoScan, which is used to treat infection and inflammation in bones for patients with suspected osteomyelitis, including patients with diabetic foot ulcers. Immunomedics, Inc. has a license and collaboration agreement with Nycomed GmbH to develop, manufacture, and commercialize veltuzumab in the subcutaneous formulation for the treatment of various non-cancer indications; and a partnership and cross-licensing agreement with Alexis Biotech Ltd., to develop vaccines against cancers that include melanoma and chronic lymphocytic leukemia, and infectious diseases, such as AIDS. The company was founded in 1982 and is headquartered in Morris Plains, New Jersey.
Advisors' Opinion:- [By Wallace Witkowski]
Immunomedics Inc. (IMMU) �shares rose 19% to $6.18 on heavy volume after the small cap biotech said it just started treating patients with its pancreatic cancer drug in a late-stage clinical trial.
- [By Sean Williams]
In terms of clinical data, small-cap biotechnology company Immunomedics (NASDAQ: IMMU ) jumped by double digits after reporting early stage, but nonetheless positive, data from its antibody-drug conjugate program. Two of Immunomedics' ADC's, IMMU-130 which is targeted at metastatic colorectal cancer, and IMMU-132, which is being tested on 13 different cancer types, demonstrated tumor shrinkage and some partial responses. We're still a long way from an approval, but ADC's certainly look like one pathway to effectively treating cancer. Make sure this is a company you've added to your Watchlist.
- [By Sean Williams]
What: Shares of Immunomedics (NASDAQ: IMMU ) , a biopharmaceutical company researching monoclonal, antibody-based products to treat cancer and other autoimmune disorders, jumped as much as 15% after providing a clinical update on its antibody-drug conjugate programs.
Hot Shipping Stocks To Invest In 2014: Nissan Motor Co Ltd (NSANY)
Nissan Motor Co., Ltd. is engaged in the manufacturing, sales and related business of automotive products, industrial machinery and marine equipment. The Company has two business segments: automobile and sales financing. The automobile segment is engaged in the passenger cars, trucks, buses, forklifts, manufacturing parts for oversea production. The sales financing segment is engaged in credit, lease. The Sales financing segment consists of Nissan Financial Services Co., Ltd. (Japan), Nissan Motor Acceptance Corporation (USA), NR Finance Mexico S.A. de C.V. SOFOM E.N.R (Mexico) and other seven companies, totaling 10 companies, and sales finance operations of Nissan Canada Inc. (Canada).
The Company has four production bases in Japan, United States, Spain, and Sweden, producing approximately 30,000 units annually for distribution in 85 countries. The Company has geographic operations in various countries, which include North America, Europe and Other. North America consists of The United States of America, Canada, and Mexico; Europe consists of France, The United Kingdom, Spain and other European countries, and Other, which includes Asia, Oceania, the Middle East, Central and South America excluding Mexico, and South Africa.
Advisors' Opinion:- [By Dan Carroll]
Nissan (NASDAQOTH: NSANY ) expressed optimism, projecting 16% sales growth at its Chinese joint venture in 2013. The announcement buoyed the car company's stock, sending Nissan's shares up 2.6% over the past week. Nissan is targeting younger Chinese consumers in particular, attempting to lay the foundations of a strong future in the world's largest car market by vehicle sales.
- [By John Rosevear]
It may not look like much now, but look carefully
The first BMW i vehicle won't be a direct Tesla competitor. The BMW i3, shown above, will launch later this year. It's a lightweight small electric car that seems aimed more at Nissan's (NASDAQOTH: NSANY ) LEAF and General Motors' (NYSE: GM ) Chevy Volt hybrid than at Tesla. - [By Ben Levisohn]
Tesla’s stock has dropped 1.2% to $173.08 at 11:43 a.m., joining other automakers in the red today.�General Motors�(GM) has dropped 0.7% to $37.20, Toyota Motor (TM) has declined 0.6% to $128.88 and Nissan (NSANY) is off 4.5% at $17.61 after it cut its earnings outlook.�Ford�(F), however, has bucked the weakness by gaining 0.3% to $17.05.
Hot Shipping Stocks To Invest In 2014: Vanguard Large Cap Etf (VV)
Vanguard Large-Cap ETF, formerly known as Vanguard Large-Cap VIPERs, is an exchange-traded share class that seeks to track the investment performance of the Morgan Stanley Capital International (MSCI) US Prime Market 750 Index (Index). The Fund employs an indexing approach to provide exposure to predominantly large-cap companies in the United States, diversified across growth and value styles.
The Index represents the universe of predominantly large-capitalization companies in the United States equity market. Using full replication, the Fund invests in all of the Index stocks, holding each stock in approximately the same proportion as its weighting in the Index.
Advisors' Opinion:- [By Selena Maranjian]
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some large-cap stocks to your portfolio but don't have the time or expertise to hand-pick a few, the Vanguard Large-Cap ETF (NYSEMKT: VV ) could save you a lot of trouble. Instead of trying to figure out which large-cap stocks will perform best, you can use this ETF to invest in lots of them simultaneously.
The basics
ETFs often sport lower expense ratios than their mutual-fund cousins. This ETF, focused on large-cap stocks, sports a relatively low expense ratio -- an annual fee -- of 0.1%. It yields about 2%.
This ETF has performed reasonably, but it's also very young, with just a few years on the books. It underperformed the S&P 500 in 2008 and 2010, though it beat it substantially in 2007 and 2009. As with most investments, of course, we can't expect outstanding performances in every quarter or year. Investors with conviction need to wait for their holdings to deliver.
No comments:
Post a Comment